Davis Investment Partners LLC Purchases 32,406 Shares of First Trust Nasdaq Pharmaceuticals ETF $FTXH

Davis Investment Partners LLC purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) in the 3rd quarter, Holdings Channel.com reports. The fund purchased 32,406 shares of the company’s stock, valued at approximately $1,344,000.

A number of other large investors also recently made changes to their positions in the business. Oppenheimer & Co. Inc. acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the third quarter worth $6,014,000. D.A. Davidson & CO. purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF in the third quarter valued at $3,702,000. Cyndeo Wealth Partners LLC purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF in the third quarter valued at $1,524,000. Trust Co. of Oklahoma acquired a new position in First Trust Nasdaq Pharmaceuticals ETF in the third quarter valued at $1,283,000. Finally, Nilsine Partners LLC increased its stake in First Trust Nasdaq Pharmaceuticals ETF by 3.5% in the second quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock valued at $1,071,000 after purchasing an additional 937 shares during the last quarter.

First Trust Nasdaq Pharmaceuticals ETF Trading Down 0.0%

First Trust Nasdaq Pharmaceuticals ETF stock opened at $44.36 on Wednesday. The stock has a fifty day moving average price of $41.95 and a 200 day moving average price of $37.56. First Trust Nasdaq Pharmaceuticals ETF has a 52 week low of $30.69 and a 52 week high of $45.10. The firm has a market capitalization of $1.20 billion, a P/E ratio of 32.96 and a beta of 0.45.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Thursday, September 24th were paid a $0.0113 dividend. This represents a $0.05 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date of this dividend was Thursday, September 24th. This is a negative change from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.